Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Feb;47(1):107-113.
doi: 10.1007/s00240-018-1090-6. Epub 2018 Nov 26.

Empiric therapy for kidney stones

David S Goldfarb  1   2
Affiliations
Review

Empiric therapy for kidney stones

David S Goldfarb. Urolithiasis. 2019 Feb.

Abstract

Careful phenotyping of patients to classify those with kidney stones has a long and important history in revealing the chemical basis for stone formation. Advances in our genetic understanding of kidney stones will lead to incredible insights regarding the pathophysiology of this common disorder. At this time, both evaluation of urine chemistry and genotyping of patients are extremely useful in the setting of a university and research-based kidney stone clinic. For much of the world, in a more clinically focused setting, these techniques are neither available nor absolutely necessary. Careful implementation of an empiric prescription based on stone composition would have an important effect to reduce stone recurrence in the world's many stone formers. Increased fluid intake, generic dietary manipulations, and prescription of potassium citrate and thiazides are all appropriate empiric therapies for people with calcium and uric acid kidney stones.

Keywords: Diet; Genetics; Kidney calculi; Nephrolithiasis; Potassium citrate; Thiazides; Uric acid; Urolithiasis.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest Goldfarb: consultant: Alnylam, Retrophin; funding from NIDDK, NCATS.

References

    1. Edvardsson VO, Goldfarb DS, Lieske JC, Beara-Lasic L, Anglani F, Milliner DS, Palsson R (2013) Hereditary causes of kidney stones and chronic kidney disease. Pediatr Nephrol 28(10):1923–1942 - PMC - PubMed
    1. Goldfarb DS, Fischer ME, Keich Y, Goldberg J (2005) A twin study of genetic and dietary influences on nephrolithiasis: a report from the Vietnam Era Twin (VET) Registry. Kidney Int 67(3):1053–1061 - PubMed
    1. Milose JC, Kaufman SR, Hollenbeck BK, Wolf JS Jr, Hollingsworth JM (2014) Prevalence of 24-hour urine collection in high risk stone formers. J Urol 191(2):376–380 - PubMed
    1. Pak CY, Britton F, Peterson R, Ward D, Northcutt C, Breslau NA, McGuire J, Sakhaee K, Bush S, Nicar M, Norman DA, Peters P (1980) Ambulatory evaluation of nephrolithiasis. Classification, clinical presentation and diagnostic criteria. Am J Med 69(1):19–30 - PubMed
    1. Pearle MS, Goldfarb DS, Assimos DG, Curhan G, Denu-Ciocca CJ, Matlaga BR, Monga M, Penniston KL, Preminger GM, Turk TM, White JR, American Urological A (2014) Medical management of kidney stones: AUA guideline. J Urol 192(2):316–324 - PubMed

LinkOut - more resources